ArticleFrontiers in pediatrics2025
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autosomal dominant intellectual disability type 39 (MRD39; OMIM # 616521) is caused by heterozygous mutation in the Case summary: We report a 1-year-6-month-old girl presenting with global developmental delay (GDD) and autistic behaviors, demonstrating inability to stand independently, crawling mobility, poor response to name calling, and impaired joint attention. Initial developmental assessments yielded a Griffiths Mental Development Scale score of 57 and an ADOS-2 score of 11. Following 20 months of systematic rehabilitative training, the patient achieved independent ambulation, could follow simple commands, and produced phrases under 10 words, though suboptimal response to name calling and joint attention persisted. Re-evaluation showed a Griffiths score of 59 and an ADOS-2 score of 10. Whole-exome sequencing identified a Conclusion: We report a case of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.